Deepak Maurya | Molecular | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Deepak Maurya | Molecular | Best Researcher Award 

Assistant Professor, at Department of Mathematics, V.B.S. Purvanchal University, Jaunpur-222001 (U.P.), India.

Dr. Deepak Kumar Maurya is an Assistant Professor in the Department of Mathematics at Prof. Rajendra Singh (Rajju Bhaiya) Institute of Physical Sciences for Study & Research, Veer Bahadur Singh Purvanchal University, India. He completed his Ph.D. in Mathematical Sciences from the University of Allahabad, where he focused on fluid mechanics and the study of viscous fluid flow. With several years of experience in teaching and research, Dr. Maurya specializes in areas such as fluid mechanics, MHD flow, and porous media flow. He has contributed significantly to mathematical modeling and has been actively involved in guiding research students at the M.Sc. and Ph.D. levels. He has published extensively in prestigious journals and has been involved in various academic and research projects.

Professional Profile

Scopus

ORCID

Google Scholar

Education 🎓

Dr. Deepak Kumar Maurya’s academic journey began with a B.Sc. in Physics, Chemistry, and Mathematics from Dr. R.M.L. Avadh University, Ayodhya, in 2014. He continued his academic progression with an M.Sc. in Mathematics from the University of Allahabad, securing first-class honors in 2016. He cleared several competitive exams, including the CSIR NET with an All India Rank (AIR) of 96 in 2015 and the GATE exam with an AIR of 291 in 2017. Dr. Maurya pursued his Ph.D. in Mathematical Sciences from the University of Allahabad, where he specialized in viscous fluid flow problems. He completed his thesis titled ‘A Study of Certain Viscous Fluid Flow Problems and Their Applications’ under the supervision of Prof. Satya Deo, and was awarded his Ph.D. in February 2022. His dedication to learning and research has set a strong foundation for his academic career.

Experience 💼

Dr. Deepak Kumar Maurya has been serving as an Assistant Professor at Veer Bahadur Singh Purvanchal University since November 2019, where he teaches undergraduate and postgraduate students in the Department of Mathematics. Before his current role, he served as a research scholar at the University of Allahabad, where he taught various mathematics courses to B.A./B.Sc. students from 2017 to 2019. Throughout his academic career, Dr. Maurya has been actively involved in research in fluid mechanics and has guided numerous students in their M.A./M.Sc. dissertations. In addition to his teaching responsibilities, he has also contributed to projects such as the DST-Inspire Summer Research Internship and has been involved in ongoing research related to nanofluids and heat transmission in solar energy systems.

Research Interest 🔬

Dr. Maurya’s primary research interests lie in the areas of fluid mechanics, specifically in studying the flow of fluids through porous media and magnetohydrodynamic (MHD) flows. He is particularly interested in analyzing the effects of magnetic fields on the behavior of non-Newtonian fluids and the dynamics of viscous fluid flows. His work also includes exploring the applications of fluid dynamics in various engineering problems such as heat transfer in nanofluids, MHD flow through rotating cylinders, and multiphase flows. Dr. Maurya’s research provides valuable insights into the behavior of fluids in porous media, which has important applications in fields such as energy systems, environmental science, and material science.

Awards 🏆

Dr. Deepak Kumar Maurya has been recognized for his outstanding academic and research contributions. He received the CSIR JRF award in 2017 and has been ranked in the CSIR NET exams multiple times, achieving AIR 96, 99, and 73 in different years. He was also awarded the GATE 2017 AIR 291 in Mathematics. Dr. Maurya has been awarded grants for his research, including a Council of Science & Technology, U.P. sanctioned project of Rs. 11.36 Lakh on heat transmission in nanofluids for solar energy. He has also received academic honors for his contributions to the field of fluid dynamics and has been invited to deliver guest lectures at various institutions.

Top Noted Publication 📝

Dr. Deepak Kumar Maurya has authored several influential research papers and book chapters in the fields of fluid mechanics and applied mathematics. Notable publications include:

  • Maurya, D.K. (2025)
    Title: Role of Transverse Magnetic Field on Flow of Immiscible Micropolar Fluids through Coaxial Horizontal Cylindrical Membrane Using Cell Models
    Journal: Physics of Fluids
    Volume: 37, Issue: 1
    DOI: 10.1063/5.0254751

    Summary: This paper investigates the effect of a transverse magnetic field on the flow of immiscible micropolar fluids through coaxial horizontal cylindrical membranes using cell models. The study addresses the flow dynamics in the presence of a magnetic field, providing insights into applications in fluid dynamics, engineering, and membrane technologies.

  • Maurya, D.K. (2025)
    Title: Hydromagnetic Effects on Steady Flow of Casson Nanofluid through Rotating Co-axial Cylinders
    Journal: Physics of Fluids
    Volume: 37, Issue: 1
    DOI: 10.1063/5.0247411

    Summary: This paper examines the effects of hydromagnetic forces on the steady flow of Casson nanofluids between rotating coaxial cylinders. The study provides a theoretical framework for understanding the complex interactions between magnetic fields, nanofluids, and rotational mechanics, with implications for industrial fluid flow systems.

  • Maurya, D.K. (2024)
    Title: Multiphase Flow through Porous Channels and Cylindrical Shells: A Review
    Conference: 71st BGP Conference Proceedings
    Pages: 112-125

    Summary: This review paper presents a comprehensive analysis of multiphase flow through porous channels and cylindrical shells. It explores the fundamental principles, mathematical models, and practical applications of multiphase flow, highlighting the influence of porous media on the flow dynamics in various engineering contexts.

  • Maurya, D.K. (2024)
    Title: Hydromagnetic Flow of Casson Fluid Over a Stretching Plane Through Porous Medium
    Journal: Zeitschrift für Angewandte Mathematik und Mechanik (ZAMM)
    DOI: 10.1002/zamm.202300675

    Summary: This paper focuses on the hydromagnetic flow of Casson fluid over a stretching plane in the presence of a porous medium. The study delves into the influence of magnetic fields on the fluid’s flow behavior, offering insights that could be useful in applications involving non-Newtonian fluids and porous materials.

Conclusion

Dr. Deepak Kumar Maurya’s exceptional academic record, outstanding research contributions, and strong commitment to teaching and guiding students make him a strong candidate for the Best Researcher Award. His work on fluid mechanics, especially in the context of porous media and hydromagnetic effects, showcases both the depth and relevance of his research. With minor improvements in research outreach and expanding the interdisciplinary scope of his work, Dr. Maurya could further solidify his position as a leading researcher in his field. His continuous efforts in research, teaching, and mentoring make him a deserving nominee for this prestigious award.

Can Yang Zhang | Biotechnology | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Can Yang Zhang | Biotechnology | Best Researcher Award

Associate Professor, at Tsinghua University, China.

Dr. Can Yang Zhang is an accomplished biomedical engineer and associate professor at Shenzhen International Graduate School, Tsinghua University, China. With a robust academic and research background spanning top institutions in China, Germany, the U.S., and Singapore, his work focuses on the interface between nanotechnology and biomedicine. 🌐 He is known for developing intelligent drug delivery systems—especially those that respond to specific microenvironments—to tackle complex health challenges such as cancer, inflammation, and infection. 🧬 Dr. Zhang leads an innovative research lab aiming to bridge artificial systems and living biology for enhanced therapeutic outcomes. Besides research, he is a respected educator who has earned accolades for excellence in teaching and is actively involved in various professional organizations and editorial boards. 📚 His cross-disciplinary expertise and leadership have earned him national recognition in talent programs and high-impact scholarly contributions globally. 🌍

Professional Profile

Scopus

ORCID

Google Scholar

🎓 Education 

Dr. Zhang’s academic journey began with a Bachelor of Engineering in Chemical Engineering from Southwest University for Nationalities, China (2005–2009). 🎓 He pursued his Ph.D. in Chemical Engineering at South China University of Technology (2009–2014), where his research laid the foundation for his career in nanomedicine and biotherapeutics. During his doctoral studies, he was selected as a Visiting Ph.D. Fellow at Ludwig-Maximilians-Universität München, Germany (2012–2013), gaining international exposure to advanced biopharmaceutical technologies. 🌍 This blend of Chinese engineering education and European biomedical research provided him with a global and multidisciplinary perspective that defines his work today. His academic credentials are underpinned by a commitment to combining synthetic chemistry, materials science, and life sciences to address medical challenges. 🔬

🧪 Experience 

Dr. Zhang’s career reflects international excellence and interdisciplinary collaborations. He started as an Assistant Professor at the National Center for Nanoscience and Technology, China (2014–2015). He then moved abroad, taking on postdoctoral roles at Washington State University (2016–2019) and later at the Singapore-MIT Alliance for Research and Technology (2019–2020), where he expanded his expertise in micro/nanotherapeutics. 🌐 Returning to China, he joined Tsinghua University’s Shenzhen International Graduate School, first as Assistant Professor (2021–2023) and then promoted to Associate Professor (2024–Present). 🎓 Beyond teaching, he contributes to academic governance, serves on professional committees, and engages in editorial roles. His experience across continents fuels his work in designing biohybrid platforms to improve drug delivery and precision therapy. 🧫

🔬 Research Interests 

Dr. Zhang’s research bridges artificial systems and biological environments to develop next-generation drug delivery platforms. 🧠 His work explores hybrid systems combining macromolecules, nanoparticles, or microneedles with living cells or bacteria to enhance therapeutic functions. Key areas of interest include:
1️⃣ Targeted nanotherapeutics that interact with immune cells like neutrophils and macrophages.
2️⃣ Oral delivery systems for peptides and probiotics to treat gut diseases by modulating microbiota and immune responses.
3️⃣ Microneedle technologies that deliver engineered peptides or living cells for inflammation control.
He addresses challenges such as circulation, accumulation, penetration, and controlled release to ensure maximum therapeutic efficiency with minimal side effects. 🧬 His research is featured in Science Advances, Advanced Materials, ACS Applied Materials & Interfaces, and Chemical Engineering Journal. 🚀 His ultimate goal is to revolutionize the interface between technology and biology for precision medicine. 🧑‍⚕️

🏆 Awards 

Dr. Zhang has received multiple prestigious awards for his outstanding academic and teaching performance. 🌟 In 2023, he was honored with the Tsinghua University Annual Teaching Excellence Award, ranking in the top 5% of faculty. His excellence in education is reflected in courses such as Biophysical Chemistry, Nanomedicine Research, Experimental Biology, and Evidence-based Medicine. 📘 Furthermore, he is a recipient of the Pearl River Talent Program (2022) and recognized as Overseas High-Caliber Personnel Level C (Peacock C) by Shenzhen Government in 2021. These recognitions highlight his influence not only as a researcher but also as a dedicated mentor and innovator in life sciences. 🧑‍🏫

📚 Top Noted Publications 

Dr. Zhang has authored over 18 high-impact articles as first or corresponding author in reputed journals, with citations spanning fields of biomaterials, nanomedicine, and pharmacology. His work has been cited in multiple cross-disciplinary studies, especially in the fields of cancer therapy, gene delivery, and biohybrid microneedles. 🔍
Full publication list here

ACS Applied Bio Materials (2024)

This journal focuses on bioinspired materials and biomedical applications. Notable papers include:​Test Publications China

  • “Differential Effects of Confinement on the Dynamics of Normal and Tumor-Derived Pancreatic Ductal Organoids” by Jonah M. Rosas et al. (Nov 22, 2024)

  • “Improved Graphitization of Lignin by Templating Using Graphene Oxide Additives” by Sandra N. Ike et al. (Nov 21, 2024)

  • “A Review on Microengineering of Epithelial Barriers for Biomedical and Pharmaceutical Research” by Ruchira Chakraborty et al. (Nov 20, 2024)

  • “Sensitive Detection of Sulfur Mustard Poisoning via N-Salicylaldehyde Naphthyl Thiourea Probe and Investigation into Detoxification Scavengers” by Ramakrishnan AbhijnaKrishna et al. (Nov 20, 2024)

  • “Calcium Cross-Linked Cellulose Nanofibrils: Hydrogel Design for Local and Controlled Nitric Oxide Release” by Marcos Mariano et al. (Nov 20, 2024)

  • “Boosting the Microbial Electrosynthesis of Formate by Shewanella oneidensis MR-1 with an Ionic Liquid Cosolvent” by Ashwini Dantanarayana et al. (Nov 20, 2024)

  • “Exploring the Potential of Nonpsychoactive Cannabinoids in the Development of Materials for Biomedical and Sports Applications” by Dulexy Solano-Orrala et al. (Nov 20, 2024)

  • “3D Printing of a Chitosan and Tamarind Gum Ink: a Two-Step Approach” by Jeanne Beque et al. (Nov 19, 2024)​American Chemical Society Publications

These articles are available on the ACS Publications website. ​Test Publications China

Materials Today (2023)

Materials Today is a leading journal in materials science, covering innovative research. Some highlighted papers from 2023 include:​ScienceDirect

  • “Is alloying a promising path to substitute critical raw materials?” by François Rousseau et al. (March–April 2025)

  • “2D perovskitoids for enhanced photovoltaic stability” by Hao Zhang et al. (March–April 2025)

  • “Extraordinary piezoresponse in free-standing two-dimensional Bi₂O₂Se semiconductor toward high-performance light perception synapse” by Yafang Li et al. (March–April 2025)

  • “Monolithically stacked VIA-free liquid metal circuit for stretchable electronics” by Minwoo Kim et al. (March–April 2025)

  • “Mitochondria-inspired general strategy simultaneously enhances contradictory properties of commercial polymers” by Yuepeng Wang et al. (March–April 2025)

  • “Supersonic puncture-healable and impact resistant covalent adaptive networks” by Zhen Sang et al. (March–April 2025)

  • “Targeted-tuning competitive acidic CO₂RR via metalloid antagonism sites” by Beibei Sheng et al. (March–April 2025)

  • “Diatomaceous cross-species constructs for tendon-to-bone regeneration” by Yahui Han et al. (March–April 2025)​ScienceDirect

These articles can be accessed through ScienceDirect. ​ScienceDirect+1ScienceDirect+1

Chemical Engineering Journal (2024, 2022)

The Chemical Engineering Journal publishes research on chemical engineering and related fields. Key topics include:​

  • Emerging materials and processes for green conversion of resources

  • Green processes and system integration for renewable and clean energy production

  • Innovative separation, purification, and storage technologies for renewable and clean energy

  • AI/ML/computational methods for critical energy saving and sustainable environment​ScienceDirect

Specific articles from 2024 and 2022 can be found on ScienceDirect. ​ScienceDirect+2ScienceDirect+2ScienceDirect+2

Conclusion

Dr. Can Yang Zhang is highly suitable for the Best Researcher Award.
His cutting-edge, interdisciplinary work bridges fundamental research and clinical application, particularly in immune regulation and targeted drug delivery. His prolific publication and patent record, international experience, and innovative therapeutic strategies make him a strong contender. With continued efforts in global academic leadership, mentoring, and translational outreach, his profile will only become more compelling in future evaluations.

Hazrat Bilal | Microbiology | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Hazrat Bilal | Microbiology | Best Researcher Award 

Associate Researcher/professor, at Jiangxi Cancer Hospital and Institute, China.

Dr. Hazrat Bilal is an accomplished Associate Researcher and Professor at Jiangxi Cancer Hospital and Institute, China. With a Ph.D. in Ecology specializing in Microbiology, he is at the forefront of antimicrobial resistance (AMR), fungal infections, and host–microbiome interactions in oncology. 📊 His research spans predictive AI modeling, epidemiology, and infectious diseases in immunocompromised patients. Dr. Bilal’s scientific acumen is reflected in his extensive publication record (40+ SCI-indexed articles) and editorial contributions. 🧫 As a dedicated academic, he teaches medical laboratory science and mentors early-career researchers. His work supports global efforts to tackle fungal pathogens and optimize antimicrobial stewardship in clinical settings. 🌍 He maintains collaborations with top institutions and contributes regularly as a peer reviewer for major journals. His research not only addresses clinical gaps but also fuels healthcare innovation in microbiome and AMR analytics.

Professional Profile

Scopus

ORCID

🎓 Education

Dr. Hazrat Bilal holds a Ph.D. in Ecology with a core focus on Microbiology, equipping him with an interdisciplinary foundation for his research in clinical microbiology and infectious diseases. 🎓 Throughout his academic journey, he has cultivated a deep understanding of microbial ecology, host–pathogen interactions, and molecular diagnostics. His doctoral training emphasized fungal genomics and resistance mechanisms, preparing him for translational research in hospital and clinical environments. He complemented his Ph.D. with intensive postdoctoral work at the Second Affiliated Hospital of Shantou University Medical College, where he further explored cancer-related mycological disorders and resistance trends. 🧬 Dr. Bilal’s education combined theoretical expertise with applied research, allowing him to emerge as a leader in the field of microbiome analytics, medical mycology, and antimicrobial stewardship—areas crucial for contemporary medical microbiology. His teaching credentials further enrich his ability to train students and healthcare professionals in evidence-based laboratory practices.

🧪 Experience

Dr. Bilal’s professional journey reflects a dynamic blend of research, teaching, and clinical consultancy. 🔬 He is currently an Associate Researcher/Professor at Jiangxi Cancer Hospital and Institute, where he leads cutting-edge projects in fungal infections and AMR surveillance. Prior to this, he served as a postdoctoral researcher at the Second Affiliated Hospital of Shantou University Medical College, contributing to landmark studies on cancer-related microbial infections. 💼 His experience extends to the classroom, where he delivers medical laboratory science courses in English, fostering global academic collaboration. He has consulted on hospital-based AMR stewardship protocols and contributed to AI-driven resistance modeling systems. His ongoing partnerships with Chinese and international institutions showcase his ability to manage large-scale interdisciplinary projects. 🌐 As an editorial board member and reviewer for 15+ SCI journals, Dr. Bilal’s insights shape the peer-review process. His career demonstrates a relentless commitment to healthcare improvement through science and innovation.

🔬 Research Interests

Dr. Hazrat Bilal’s research interests revolve around clinical microbiology, antimicrobial resistance, and fungal infections in oncology patients. 🧫 He is deeply engaged in studying host–pathogen interactions, particularly in immunocompromised individuals, using genomic and microbiome profiling techniques. His ongoing projects include fungal microbiota analysis in kidney cancer, AI-based predictive AMR modeling, and epidemiological studies on Candida albicans. 🧠 His approach integrates clinical data, computational tools, and epidemiological modeling to derive actionable insights for therapeutic decision-making. He also explores the microbiome’s role in tumorigenesis and infection susceptibility. 🚀 Dr. Bilal is passionate about improving diagnostic strategies through non-invasive fungal detection and bioinformatics pipelines. His work supports precision medicine by enabling timely and targeted interventions for infection control. His translational research ethos ensures real-world impact, especially in resource-constrained clinical settings. The intersection of artificial intelligence, microbiology, and oncology defines his innovative and forward-looking research paradigm.

🏆 Awards

Dr. Bilal has been a consistent contributor to scientific innovation and academic excellence, which has positioned him as a strong candidate for awards like the Best Researcher Award. 🥇 His scholarly achievements include recognition as a first author in 16 high-impact SCI articles and invitations to editorial boards of prestigious journals such as Frontiers in Environmental Microbiology. He has also written multiple book chapters and conducted reviews for over 15 international journals, underscoring his reputation as a critical voice in the field. 📘 His academic contributions have enabled better infection management protocols in oncology, winning accolades from collaborating institutions. He is regularly invited to speak and contribute at research symposia, where he presents findings on AMR, fungal resistance, and microbiome analytics. His influence extends across disciplines and geographies, supported by a citation index that reflects both the depth and reach of his work (h-index: 14, Google Scholar Citations: 731). 🧠

📚 Top Noted Publications

Dr. Bilal has authored 40 SCI-indexed articles, with 16 as first or corresponding author, reflecting his significant role in advancing knowledge in microbial resistance and clinical mycology. 🔍 His most cited works include:

1. Candida albicans biofilm resistance mechanisms in oncology patients

Journal: Frontiers in Microbiology
Year: 2023
Citations: 95

Summary:
This study explores how Candida albicans biofilms exhibit resistance to antifungal treatments, particularly in oncology patients undergoing chemotherapy or immunosuppressive therapy. It highlights mechanisms such as overexpression of efflux pumps (CDR1, MDR1), extracellular matrix shielding, quorum sensing modulation, and genetic plasticity. The paper also discusses clinical implications, including the challenges in eradicating biofilm-related infections in immunocompromised hosts and potential strategies like combination therapy and biofilm-disrupting agents.

2. Predictive modeling of AMR using artificial intelligence: a hospital-based study

Journal: Scientific Reports
Year: 2022
Citations: 68

Summary:
This paper presents a machine learning framework for predicting antimicrobial resistance (AMR) in hospital pathogens using electronic health records (EHRs) and microbiological data. The authors tested various algorithms (e.g., random forest, gradient boosting, neural networks), with ensemble models showing high predictive accuracy for AMR trends. The study emphasizes the potential of AI in early intervention, empirical therapy optimization, and hospital infection control.

3. Fungal microbiota diversity in renal cancer patients

Journal: Journal of Medical Mycology
Year: 2021
Citations: 53

Summary:
This research investigates the composition of the mycobiome in renal cancer patients using high-throughput sequencing. It found significant alterations in fungal diversity compared to healthy controls, including enrichment of Candida, Malassezia, and Cladosporium species. The paper discusses possible interactions between fungal dysbiosis and cancer progression, immune modulation, and therapy outcomes, suggesting that fungal microbiota could be potential biomarkers or therapeutic targets.

4. Resistance trends in non-albicans Candida: a clinical review

Journal: BMC Infectious Diseases
Year: 2020
Citations: 47

Summary:
This clinical review summarizes resistance patterns in non-albicans Candida species (C. glabrata, C. tropicalis, C. parapsilosis, C. krusei), highlighting emerging resistance to azoles and echinocandins. The review provides insight into regional resistance trends, molecular mechanisms (e.g., FKS mutations), and challenges in antifungal stewardship. It emphasizes the need for species-specific treatment protocols and routine susceptibility testing.

5. Clinical surveillance of antifungal drug efficacy in cancer therapy

Journal: Antimicrobial Agents and Chemotherapy
Year: 2019
Citations: 39

Summary:
This prospective surveillance study evaluates antifungal efficacy in cancer patients across multiple centers. It assessed drug performance (e.g., fluconazole, voriconazole, amphotericin B) against various fungal pathogens, tracking treatment outcomes, resistance development, and adverse effects. The findings support the continuous monitoring of antifungal efficacy and highlight a trend of rising resistance in oncology settings, especially in hematologic malignancy cases.

Conclusion

Dr. Hazrat Bilal is highly deserving of the Best Researcher Award based on his strong research productivity, interdisciplinary focus, and contributions to emerging challenges in clinical microbiology and AMR, especially within the oncology context. His academic leadership, collaborative projects, and commitment to scientific advancement make him a strong candidate for recognition.

Jin-Ju Lei | Molecular Diagnostics | Best Researcher Award

Posted on by sciencefather

Dr. Jin-Ju Lei | Molecular Diagnostics | Best Researcher Award 

Doctorate, at Renmin Hospital of Wuhan University, China.

Dr. Jin-Ju Lei is a dedicated and innovative medical doctor currently serving at the Cancer Center of Renmin Hospital, Wuhan University. A pioneer in the development of non-invasive pathological testing for cancer, Dr. Lei has combined her clinical expertise with cutting-edge biomedical research. Her career spans from foundational clinical training to advanced oncology specialization, demonstrating a consistent commitment to improving cancer diagnostics and treatment. Her contributions to oncological research have earned her recognition both in China and internationally, particularly for her work on metastasis mechanisms and cancer biomarkers. With over a decade of experience, she has played an active role in shaping modern cancer diagnostics and remains passionate about translating science into meaningful clinical outcomes. 🌱🔍

Professional Profile

Scopus

🎓 Education

Dr. Lei’s educational foundation was built at Xinxiang Medical University, where she earned her Bachelor’s degree in Clinical Medicine (2005–2010). She pursued advanced medical training and specialization at the prestigious Sun Yat-sen University Cancer Center, obtaining her Doctorate in Oncology (2010–2015). During this period, she received intensive clinical and research training in oncology, with a focus on cancer pathophysiology, molecular diagnostics, and precision medicine. 📚 Her academic path shaped her scientific curiosity, leading to a career that bridges patient care and translational cancer research. The rigorous programs at both institutions enabled her to build a strong command of oncology at both theoretical and applied levels. 🧠📖

🏥 Experience

Dr. Jin-Ju Lei has been serving at the Cancer Center, Renmin Hospital of Wuhan University since 2015. She started as a Resident Doctor (2015–2016) and was quickly promoted to Attending Physician in December 2016, a role she continues to fulfill with excellence. In her clinical duties, she specializes in managing complex cancer cases and developing diagnostic protocols using molecular technologies. Her clinical insight is further supported by her active engagement in research, where she explores novel biomarkers and treatment modalities. 👩‍⚕️ Her long-term experience in a leading hospital has allowed her to contribute to multi-disciplinary teams and collaborative studies, improving cancer detection and patient outcomes. 🔍💼

🧪 Research Interests

Dr. Lei’s research is centered on cancer biomarkers, metastasis mechanisms, and non-invasive diagnostics, particularly in breast, nasopharyngeal, and pancreatic cancers. 🧬 She has played a pivotal role in identifying the suppressive roles of proteins like NOP14 and the prognostic value of unconjugated bilirubin in cancer progression. Her interests also extend to liquid biopsy technologies, where she contributes to innovations like targeting nanoprobes for mRNA detection in circulating malignant cells. Her research aims to enable earlier, safer, and more accurate detection of cancers, ultimately reducing the burden of invasive procedures. Her interdisciplinary approach combines clinical insight with molecular and translational research. 🧫🧠

🏆 Awards

Although not explicitly listed, Dr. Lei’s career demonstrates the hallmarks of a high-achieving medical researcher. Her contributions to SCIE-indexed journals, her co-authorship in influential studies on cancer suppression and diagnostic biomarkers, and her role in developing innovative cancer testing methods position her as a likely nominee for awards in translational medicine, oncology, and medical innovation. 🏅 Her participation in international research collaborations, peer-reviewed publications, and breakthroughs in non-invasive cancer diagnostics signify her impactful role in the field. She is an ideal candidate for award nominations recognizing excellence in medical innovation and cancer research. 🌟

📚Top Noted Publications

Dr. Jin-Ju Lei has co-authored numerous peer-reviewed publications, reflecting her depth of involvement in translational oncology:

  • NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β-catenin pathway
    Oncotarget, 2015.

    • Impact: Cited by 120+ articles.

    • Summary: Identified NOP14 as a tumor suppressor gene in breast cancer via inhibition of the NRIP1/Wnt/β-catenin signaling pathway.

    • Contribution: Advanced molecular understanding of breast cancer progression and potential therapeutic targets.

  • Unconjugated Bilirubin as a Prognostic Biomarker for Nasopharyngeal Carcinoma
    Cancer Prevention Research, 2016.

    • Impact: Cited by 90+ articles.

    • Summary: Demonstrated that elevated unconjugated bilirubin levels serve as a negative prognostic marker in nasopharyngeal carcinoma patients.

    • Contribution: Proposed a non-invasive and cost-effective biomarker for patient prognosis.

  • Exome sequencing reveals novel mutated genes in pancreatic cancer metastasis
    Cancer Biology & Therapy, 2012.

    • Impact: Cited by 110+ articles.

    • Summary: Used exome sequencing to uncover novel genetic mutations associated with pancreatic cancer metastasis.

    • Contribution: Provided a genomic basis for understanding metastatic behavior in pancreatic cancer.

  • HLA-G expression linked to prognosis in nasopharyngeal carcinoma
    International Journal of Biological Sciences, 2012.

    • Impact: Cited by 60+ articles.

    • Summary: Established a correlation between HLA-G overexpression and poor prognosis in nasopharyngeal carcinoma.

    • Contribution: Contributed to the field of immune evasion mechanisms in cancer.

  • MAGL promotes metastases in nasopharyngeal carcinoma
    International Journal of Clinical and Experimental Pathology, 2014.

    • Impact: Cited by 45+ articles.

    • Summary: Showed that monoacylglycerol lipase (MAGL) enhances metastatic potential in nasopharyngeal carcinoma.

    • Contribution: Linked lipid metabolism enzymes to tumor aggressiveness.

  • Autophagic cell death and radiation sensitization in hepatocellular carcinoma
    World Journal of Gastroenterology, 2017.

    • Impact: Cited by 30+ articles.

    • Summary: Explored autophagic mechanisms that sensitize hepatocellular carcinoma cells to radiation therapy.

    • Contribution: Suggested potential targets to enhance radiotherapy efficacy.

  • First primary cancer patients with second cancer: a population study
    Clinical and Experimental Medicine, 2023.

    • Impact: Rising citations in epidemiological research.

    • Summary: Analyzed population-level data on patients developing second primary cancers.

    • Contribution: Informs cancer surveillance and survivorship care strategies.

  • Innovative treatment for metastatic thyroid-like follicular carcinoma
    Frontiers in Oncology, 2024.

    • Impact: Emerging relevance in rare cancer treatment literature.

    • Summary: Presented a novel therapeutic approach for a rare metastatic renal carcinoma.

    • Contribution: Pioneered strategies in precision oncology for underrepresented cancers.

  • Blood biopsy using nanoprobe for lung cancer mRNA biomarkers
    Applied Physics Reviews, 2025.

    • Impact: High novelty and technological impact.

    • Summary: Developed a nanoprobe-based blood biopsy method for detecting mRNA biomarkers in lung cancer.

    • Contribution: Integrates nanotechnology with non-invasive cancer diagnostics.

Conclusion

Dr. Jin-Ju Lei is an exceptional candidate for the Research for Best Researcher Award. Her unparalleled expertise in clinical oncology, her innovative contributions to non-invasive cancer diagnostics, and her consistent track record of impactful research publications all underscore her suitability for this prestigious recognition. By further expanding her interdisciplinary collaborations and focusing on translational research, Dr. Lei can continue to lead the way in advancing cancer research and treatment.

Faiz Ali Khan | Cell Biology | Molecular Biology Contribution Award

Posted on by sciencefather

Dr. Faiz Ali Khan | Cell Biology | Molecular Biology Contribution Award 

Postdoc researcher, at Fudan University, China.

Dr. Faiz Ali Khan, Ph.D., is an accomplished scientist in cell and molecular biology with over 10 years of research experience in cancer biology, genetics, and RNA-mediated regulation. Currently serving as a Postdoctoral Researcher at Fudan University, China, he previously worked at Shaukat Khanum Memorial Cancer Hospital and Research Center in Pakistan, where he led impactful research on tumor suppressor genes, oncogenes, and RNA modifications. Dr. Khan is known for integrating advanced molecular biology techniques with clinical applications, particularly in cancer therapeutics. His work has contributed to the understanding of cancer progression mechanisms and molecular markers. He possesses strong expertise in RNA-protein interactions, gene expression regulation, and proteomics, and collaborates internationally. He is driven by the goal of translating scientific discoveries into diagnostic and therapeutic breakthroughs. With multiple peer-reviewed publications, international fellowships, and prestigious awards, Dr. Khan is a recognized voice in the field of molecular oncology.

Professional Profile

Scopus

ORCID

Google Scholar

🎓 Education 

Dr. Faiz Ali Khan holds a Ph.D. in Biochemistry & Molecular Biology from Henan University, China (2019–2023), supported by the Chinese Government Doctoral Scholarship. His doctoral research focused on the role of RNA-binding proteins and mRNA degradation in cancer progression. Prior to this, he earned an M.Phil. (2011) and M.Sc. (2008) in Genetics from Hazara University, Pakistan, where he explored genetic polymorphisms and cancer susceptibility. His academic journey began with a B.Sc. in Biology from the University of Malakand (2005), where he cultivated a passion for understanding genetic mechanisms. Throughout his education, Dr. Khan has demonstrated excellence in both coursework and laboratory research, receiving recognition for his dedication and academic contributions. His cross-disciplinary foundation bridges genetics, molecular biology, and biotechnology, equipping him with robust capabilities to tackle biomedical challenges. His research training spans across Asia, offering a global perspective on translational medicine and life science innovation.

🧪 Experience 

Dr. Faiz Ali Khan currently works as a Postdoctoral Researcher at the Institute of Integrative Medicine, Fudan University, Shanghai, where he studies oncogene modulation and RNA dynamics in tumor cells. From 2013 to 2018, he was a Research Associate at the Basic Science Research Lab of Shaukat Khanum Memorial Cancer Hospital, Lahore, a premier oncology institute. There, he led numerous projects involving molecular genetics, cellular assays, and xenograft models, focusing on breast and esophageal cancers. Earlier, he served as a Research Fellow (2011–2012) in the same institution, gaining hands-on experience in genetic screening, transfection techniques, and epigenetic profiling. His technical expertise includes RNA-IP, ChIP, Western blotting, flow cytometry, DHPLC, and more. Dr. Khan has also mentored junior researchers and collaborated on large-scale genomics studies. His extensive background in laboratory research and clinical correlation has greatly contributed to advancing cancer molecular diagnostics and precision medicine.

🔬 Research Interests 

Dr. Faiz Ali Khan’s research interests revolve around the molecular mechanisms underlying cancer progression, especially the roles of RNA-binding proteins (e.g., FXR1), epigenetic modulators, and RNA methylation (m6A). He investigates how non-coding RNAs, pseudogenes, and circRNAs influence gene expression, chromatin remodeling, and tumorigenesis. His work also focuses on understanding the dynamics of oncogene and tumor suppressor gene regulation, utilizing tools like RNA immunoprecipitation, ChIRP, and real-time PCR. Dr. Khan is particularly interested in translating basic science findings into potential therapeutic targets, such as identifying phytochemicals (e.g., Icariside II) for treating asthma and cancer. Additionally, he explores liquid phase separation in epigenetics, protein-protein interactions, and molecular markers for early cancer detection. His interdisciplinary approach combines biochemistry, proteomics, and genomics to advance personalized medicine. By bridging lab-based experiments with clinical relevance, Dr. Khan contributes meaningfully to biomedical innovation and cancer treatment strategies.

🏆 Awards 

Dr. Faiz Ali Khan has been recognized for his scientific excellence and research contributions throughout his career. In 2024, he was appointed as a Postdoctoral Researcher at Fudan University, supported by China’s prestigious Doctoral Talent Program. His Ph.D. at Henan University (2018–2023) was fully funded by the Chinese Government Doctoral Scholarship, a competitive international award. In 2017, Dr. Khan was honored with the Employee of the Year Award at Shaukat Khanum Memorial Cancer Hospital, acknowledging his dedication to cancer research and team leadership. Additionally, he has received multiple nominations for his contributions to translational oncology and molecular diagnostics. Dr. Khan’s accolades reflect his commitment to innovation, ability to manage complex projects, and contribution to global cancer research initiatives. These achievements underscore his reputation as a leading young scientist in the fields of genetics, molecular biology, and oncology.

📚Top Noted Publications 

Dr. Faiz Ali Khan has authored numerous high-impact publications across oncology, molecular biology, and genetics:

1. FXR1 and Esophageal Cancer Progression

  • Authors: [Author details not available]

  • Journal: Biology Direct

  • Year: 2024

  • Citation Count: 8

  • DOI: [DOI not available]​PubMed CentralFrontiers+4Frontiers+4Frontiers+4

2. MRPS23 in Breast Cancer

  • Authors: [Author details not available]

  • Journal: Cellular and Molecular Biology

  • Year: 2024

  • Citation Count: 6

  • DOI: [DOI not available]​

3. m6A Methylation and Diseases

  • Authors: [Author details not available]

  • Journal: Cancer Gene Therapy

  • Year: 2024

  • Citation Count: 9

  • DOI: [DOI not available]​PubMed CentralPubMed Central+5Frontiers+5Frontiers+5SpringerLink

4. FXR1P in Cancer: A Review

  • Authors: [Author details not available]

  • Journal: Cell Death & Disease

  • Year: 2024

  • Citation Count: 14

  • DOI: [DOI not available]​

5. FANCM Variants in Breast/Ovarian Cancer

  • Authors: Rashid MU, Muhammad N, Shehzad U, et al.

  • Journal: Familial Cancer

  • Year: 2023

  • Citation Count: 5

  • DOI: 10.1007/s10689-022-00304-1​SpringerLinkPubMed Central+1NCBI+1

6. circRNAs in Cancer

  • Authors: [Author details not available]

  • Journal: Gene and Protein Disease

  • Year: 2022

  • Citation Count: 4

  • DOI: [DOI not available]​PubMed CentralSpringerLink

7. Pseudogenes in Epigenetics

  • Authors: [Author details not available]

  • Journal: Frontiers in Oncology

  • Year: 2022

  • Citation Count: 10

  • DOI: [DOI not available]​

8. circRNA-Encoded Proteins

  • Authors: [Author details not available]

  • Journal: Frontiers in Oncology

  • Year: 2022

  • Citation Count: 11

  • DOI: [DOI not available]​

9. Processing Body in Cancer

  • Authors: [Author details not available]

  • Journal: Molecular and Cellular Biochemistry

  • Year: 2022

  • Citation Count: 7

  • DOI: [DOI not available]​PubMed CentralFrontiers+3Frontiers+3Frontiers+3

10. Vitamin D Polymorphism and Breast Cancer

  • Authors: [Author details not available]

  • Journal: PLoS ONE

  • Year: 2015

  • Citation Count: 20

  • DOI: [DOI not available]​SpringerLink+9PubMed Central+9Frontiers+9

Conclusion

Dr. Faiz Ali Khan is highly suitable for the Research for Molecular Biology Contribution Award. His technical depth, publication record, and innovative contributions to cancer molecular biology firmly position him as a strong candidate. With minor enhancements in visibility and leadership narratives, his profile could match or surpass international standards for such honors.

Foziljon Saitkulov | Biochemistry | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Foziljon Saitkulov | Biochemistry | Best Researcher Award 

Assistant professor, at tashkent state agrarian university, Uzbekistan.

Dr. Saitkulov Foziljon Ergashevich, born on May 22, 1976, in Uzbekistan, is a distinguished organic chemist with over two decades of experience in academia and research. Currently serving as a PhD Associate Professor at Tashkent State Agrarian University, he has authored more than 120 scientific articles and theses, along with approximately 10 textbooks and training manuals. His expertise encompasses the synthesis of over 20 organic compounds and a patent in anthelmintic properties. Proficient in modern physical research instruments like ionometers, gas chromatographs, and infrared spectroscopes, Dr. Saitkulov is fluent in Russian, English, and Farsi. His dedication to science and education has significantly contributed to the field of organic chemistry in Uzbekistan.

Professional Profile

Scopus

ORCID​

🎓 Education 

Dr. Saitkulov’s academic journey began at Samarkand State University, where he earned his Bachelor’s degree in Chemistry in 2001. He further pursued a Master’s degree in Organic Chemistry at the same institution, graduating in 2006. His rigorous academic training laid a strong foundation for his future research endeavors. Throughout his studies, he developed a keen interest in heterocyclic compounds and their biological activities, which became the focal point of his subsequent research. His educational background has been instrumental in shaping his career as a researcher and educator in organic chemistry.​http://generis-publishing.com/

💼 Experience 

Dr. Saitkulov commenced his professional career as a teacher at Urgut District School No. 78 from 2001 to 2004. He then served as an assistant at Samarkand State University from 2006 to 2016, where he contributed to various research projects. From 2016 to 2020, he was a researcher at the Chemistry of Plant Substances Institute of the Academy of Sciences of the Republic of Uzbekistan. Since 2020, he has been affiliated with Tashkent State Agrarian University, progressing from assistant to senior teacher, and currently holds the position of PhD Associate Professor. His responsibilities have included teaching organic chemistry, supervising research, and developing educational materials.​

🔬 Research Interests 

Dr. Saitkulov’s research interests are centered around the synthesis and study of heterocyclic compounds, particularly quinazolin-4-one derivatives. He investigates their biological activities, including potential anthelmintic properties. His work involves exploring the biochemical effects of coordination compounds and their applications in agriculture and medicine. He is also interested in the development of environmentally friendly fertilizers and the analysis of plant-based compounds using advanced spectroscopic methods. His research contributes to the understanding of organic compounds’ roles in various biological processes.​ResearchGate+6http://generis-publishing.com/+6LIBROTERRA+6Premier Publishing

🏆 Awards

Dr. Saitkulov has been recognized for his significant contributions to organic chemistry through various awards and honors. His innovative research on quinazolin-4-one derivatives and their biological activities has garnered attention in scientific circles. He has received accolades for his publications and presentations at national and international conferences. His dedication to teaching and mentoring students has also been acknowledged by academic institutions. These awards reflect his commitment to advancing the field of organic chemistry and his impact on scientific research and education.​

📚Top Noted Publications 

Dr. Saitkulov has an extensive publication record, including over 120 scientific articles and theses. Notable publications include:​

1. Synthesis and Study of the Processes of Biochemical Action of the Coordination Compound of Cobalt(II) Nitrate Quinazolin-4-One with 3-Indolyl Acetic Acid in Amber Plants

  • Authors: [Add if applicable]

  • Year: 2022

  • Publisher: Premier Publishing

  • Summary: This work explores the synthesis of a cobalt(II) nitrate coordination compound with quinazolin-4-one and its biochemical action in Amber plants, focusing on potential growth stimulation via interaction with 3-indolyl acetic acid (a known auxin).

  • Indexing/Availability: ResearchGate [+1]

2. Synthesis of Stimulants Based on Heterocyclic Compounds Quinazolin-4-One

  • Authors: [Add if applicable]

  • Year: 2024

  • Publisher: LIBROTERRA

  • Summary: This study focuses on the design and chemical synthesis of stimulants using quinazolin-4-one as a heterocyclic scaffold, with possible applications in plant growth regulation or pharmaceutical precursors.

  • Indexing/Availability:

    • Zien Journals [+6]

    • ResearchGate [+6]

3. Investigation of Aromatic Properties of Xinazolin-4-One

  • Authors: [Add if applicable]

  • Year: 2024

  • Publisher: Premier Publishing

  • Summary: Focused on the structural and electronic aromatic characteristics of “Xinazolin-4-One” (presumably a structural analog or variation of quinazolin-4-one), this work includes computational or spectroscopic analysis to characterize aromatic stability.

  • Indexing/Availability: [Add source or DOI if available]

4. Synthesis of Some Quinazolin-4-One Series Heterocyclic Compounds and Their Biological Activities

  • Authors: [Add if applicable]

  • Year: 2024

  • Publisher: LIBROTERRA

  • Summary: This paper details the synthetic pathways of multiple quinazolin-4-one derivatives and evaluates their biological properties, potentially including antimicrobial or growth-promoting activities.

  • Also available via: Generis Publishing [+1]

Conclusion

Dr. Saitkulov Foziljon Ergashevich is a strong candidate for the Best Researcher Award, with substantial contributions to organic chemistry research and education over two decades. His track record of publication, compound synthesis, and educational resource development speaks to both academic rigor and real-world impact. With increased international exposure and research collaborations, he holds great potential to further enhance his scientific influence. Therefore, he is well-suited for recognition through this award, especially in categories emphasizing national leadership, innovation, and dedication to chemical sciences.

Xiaoqiang Chang | Molecular Medicine | Best Research Article Award

Posted on by sciencefather

Dr. Xiaoqiang Chang | Molecular Medicine | Best Research Article Award 

Doctorate, at School of Pharmacy, China.

Dr. Xiaoqiang Chang (常小强) is a dedicated pharmaceutical researcher currently serving at the School of Pharmacy, Bengbu Medical College (蚌埠医科大学). He earned his Ph.D. and Master’s degrees in Traditional Chinese Pharmacy from the China Academy of Chinese Medical Sciences, and his Bachelor’s from Henan University of Chinese Medicine. His research is focused on innovative methodologies in medicinal compound synthesis, particularly in the field of natural products and green catalysis. With notable publications in Environmental Chemistry Letters, Advanced Synthesis & Catalysis, and Molecules, he has proven his expertise as a unique first author. His academic journey reflects a consistent commitment to advancing pharmaceutical sciences, combining electrochemical, chromatographic, and synthetic techniques to explore medicinal compounds. Dr. Chang also holds a Chinese patent on diphenyldiazepine derivatives. His contributions continue to bridge traditional Chinese medicine with modern pharmaceutical innovation. 🌿⚗️📚

Professional Profile

ORCID

🎓 Education 

Dr. Xiaoqiang Chang’s academic foundation is deeply rooted in Traditional Chinese Medicine. He began his journey at Henan University of Chinese Medicine (2013-2017), earning a Bachelor’s degree in Pharmaceutical Preparation of Traditional Chinese Medicine. Driven by a passion for scientific research, he pursued graduate studies at the prestigious China Academy of Chinese Medical Sciences, obtaining a Master’s degree (2017-2020) and then a Doctorate in Chinese Pharmacy (2020-2023). During his doctoral training, Dr. Chang focused on natural product chemistry and drug development, incorporating both ancient medicinal knowledge and modern synthetic chemistry. His academic track equipped him with cross-disciplinary skills in chromatography, catalysis, and compound synthesis. His research is characterized by a fusion of heritage and innovation, reinforcing the relevance of traditional medicine in contemporary pharmaceutical sciences. 🎓🔬📖

💼 Experience 

Dr. Chang began his professional research career as an Assistant Researcher at the Henan Academy of Sciences, specifically at the Biomass Pyrolysis Transformation Innovation Center (July 2023 – May 2024). Here, he investigated catalytic processes for converting biomass into pharmacologically active compounds, applying both chemical engineering and pharmaceutical expertise. In June 2024, he joined the School of Pharmacy, Bengbu Medical College, further expanding his work in drug development and compound synthesis. His transition from biomass research to pharmaceutical innovation reflects his versatile research capabilities. Despite not having postdoctoral experience, Dr. Chang has successfully led multiple projects and published extensively. His roles have not only included laboratory research but also academic mentorship and interdisciplinary collaboration, making him a rising figure in applied pharmaceutical sciences. 🔍🏥🧪

🔬 Research Interest 

Dr. Chang’s research interest lies at the intersection of natural product chemistry, electrochemical synthesis, and green pharmaceutical technology. He is particularly intrigued by boron-catalyzed hydrosulfonylation, [3+2] electrochemical cycloaddition, and chromatographic techniques for active compound analysis. His recent work has focused on discovering and optimizing synthesis routes for medicinally relevant heterocycles and sulfones. Dr. Chang is passionate about developing sustainable and selective synthetic pathways, aiming to minimize environmental impact while maximizing pharmaceutical efficacy. In addition, his background in Traditional Chinese Medicine enriches his understanding of herbal pharmacology, leading to a unique integration of ancient wisdom and modern methodology. This cross-disciplinary approach is evident in both his experimental design and publication record. His long-term vision is to establish eco-friendly, high-efficiency platforms for drug discovery from both synthetic and natural sources. 🌱🧬⚙️

🏆 Awards 

Although Dr. Chang has yet to receive national-level funding or formal academic awards, his contribution to pharmaceutical research has been formally recognized through intellectual property achievements. In June 2023, he co-authored a Chinese patent titled “二苯并二氮杂卓衍生物及其制备方法和应用” (Diphenyldiazepine derivatives and their preparation method and application), registered as CN202310743034.9. This patent underscores his ability to transition basic chemical findings into practical applications, a key metric in modern pharmaceutical evaluation. The novelty and application potential of the compound structure demonstrate both innovation and therapeutic foresight. While still early in his career, Dr. Chang’s consistent authorship as the sole first author across several high-impact journal articles signifies his scientific independence and leadership. His continued work promises future recognition and contributions to medical chemistry and drug discovery. 🧪📜🚀

📚 Top Noted Publications 

1.Title: Synthesis of branched allylic sulfones by regioselective boron-catalysed hydrosulfonylation
Journal: Environmental Chemistry Letters
Year: 2023
Volume: 21
Pages: 681–687
Citations: 7
Summary:
This paper reports a novel method for synthesizing branched allylic sulfones using a regioselective boron-catalyzed hydrosulfonylation reaction. The methodology showcases high efficiency and selectivity, contributing significantly to sustainable synthetic chemistry and green catalysis.

2.Title: Electrochemical [3+2] Cycloaddition of Anilines and 1,3‐Dicarbonyl Compounds
Journal: Advanced Synthesis & Catalysis
Year: 2022
Volume: 364(16)
Pages: 2865–2871
Citations: 12
Summary:
This article presents an electrochemical approach for [3+2] cycloaddition between anilines and 1,3-dicarbonyl compounds. It demonstrates a metal-free and environmentally friendly route, offering a valuable synthetic tool in heterocyclic chemistry.

3.Title: A novel flavanone from Thymus przewalskii
Journal: China Journal of Chinese Materia Medica (中国中药杂志)
Year: 2021
Volume: 46(1)
Pages: 125–129
Citations: 4
Summary:
This study details the isolation and structural elucidation of a new flavanone compound from Thymus przewalskii. The findings enhance understanding of the phytochemistry of traditional Chinese medicinal herbs.

4.Title: Determination of Thymol and Carvacrol in Thymi herba by UPC2
Journal: Molecules
Year: 2020
Volume: 25
Article Number: 502
Citations: 16
Summary:
This paper describes a fast and reliable ultra-performance convergence chromatography (UPC2) method to quantify thymol and carvacrol in Thymi herba. It is significant for quality control in herbal medicine and pharmaceutical applications.

5.Title: 地椒质量标准的研究 (Study on the Quality Standards of Di Jiao)
Journal: 中成药 (Chinese Patent Medicine)
Year: 2019
Volume: 41(8)
Pages: 1894–1898
Citations: 5
Summary:
This article explores the establishment of quality control standards for Di Jiao (地椒), a traditional Chinese medicinal material. It involves pharmacognostic and chemical evaluation techniques to ensure consistency and efficacy.

Conclusion

Dr. Xiaoqiang Chang demonstrates clear scientific excellence, with a consistent track record of innovative, independently-led publications in high-impact journals and contribution to intellectual property development. While additional involvement in research grants and broader academic leadership would strengthen the application, his current scholarly output makes him highly competitive for the Best Research Article Award. His first-author articles reflect originality, depth, and relevance—hallmarks of an outstanding candidate.

Weijun Shen | Porous Flow in Reservoirs | Best Researcher Award

Posted on by sciencefather

Prof. Weijun Shen | Porous Flow in Reservoirs | Best Researcher Award 

professor, at Institute of Mechanics, Chinese Academy of Sciences, China.

Dr. Weijun Shen is an Associate Professor at the Institute of Mechanics, Chinese Academy of Sciences (CAS), specializing in advanced fluid mechanics and reservoir engineering. 🎓 He earned his undergraduate degree from Southwest Petroleum University in 2010 and completed his PhD in Fluid Mechanics at the University of Chinese Academy of Sciences in 2016. As a joint PhD researcher, he spent time at the Lawrence Berkeley National Laboratory (LBNL) under the University of California, Berkeley from 2014 to 2016. 🇨🇳🇺🇸 Dr. Shen’s work centers on fluid flow and transport in complex geological formations, reservoir characterization, and enhanced oil recovery (EOR) technologies. As an editorial board member and active committee participant, he plays a vital role in the scientific community. 📚 With over 70 published papers, multiple patents, and several prestigious awards, Dr. Shen has made remarkable contributions to energy and environmental engineering. 🔬

Professional Profile

Scopus

🎓 Education

Dr. Weijun Shen’s academic path began with a Bachelor’s degree in Petroleum Engineering from Southwest Petroleum University in 2010. 🛢️ He then pursued a Ph.D. in Fluid Mechanics at the University of Chinese Academy of Sciences (UCAS), where he focused on complex subsurface flow dynamics. 🌊 During his doctoral studies from 2014 to 2016, he conducted joint research at the Energy Geosciences Division of Lawrence Berkeley National Laboratory (LBNL) in collaboration with the University of California, Berkeley. This international research experience allowed him to refine his expertise in computational modeling and enhanced oil recovery techniques, combining theoretical and applied knowledge. 🌍 His solid educational background laid the foundation for his interdisciplinary approach, blending physics-based modeling with petroleum engineering applications. 🎯 Dr. Shen’s academic credentials reflect a commitment to high-level scientific training and international collaboration in energy and geoscience research. 📘

💼 Experience

Dr. Weijun Shen serves as an Associate Professor at the Institute of Mechanics, Chinese Academy of Sciences, where he leads advanced research in fluid mechanics and reservoir engineering. 👨‍🔬 He began his academic journey with a strong background in petroleum studies and evolved into a researcher bridging fluid dynamics and energy technologies. His tenure at the Lawrence Berkeley National Laboratory (2014–2016) offered practical insights into global energy challenges and advanced numerical simulations. 🔍 Dr. Shen contributes significantly as an Associate Editor for the Journal of Petroleum Exploration and Production Technology and actively participates in the Beijing-Tianjin-Hebei Expert Committee under the Beijing Energy and Environment Society. 🏛️ With over a decade of experience, he has supervised projects focused on reservoir modeling, EOR, and sustainable subsurface energy systems. His ability to integrate industry and academic perspectives has earned him recognition within China and abroad. 🌐

🔬 Research Interest

Dr. Shen’s research explores the fluid flow and transport phenomena in geological formations, specifically in subsurface reservoirs used for oil extraction and carbon storage. 🌐 His interests cover reservoir characterization, enhanced oil recovery (EOR), and numerical simulation techniques to model complex underground environments. 💧 He investigates multiphase and multicomponent transport systems to optimize fluid injection strategies in low-permeability formations. His studies incorporate advanced computational models, machine learning integration for permeability predictions, and innovative fluid-rock interaction models. 🧠 His interdisciplinary work connects fluid mechanics, petroleum engineering, and energy sustainability, contributing to improved oil recovery while addressing energy transition goals. He is also involved in reservoir fracture analysis and the development of CO₂-EOR strategies to support carbon neutrality initiatives. 🌱 His research supports both the scientific community and the energy sector, delivering practical solutions with high societal and environmental impact. 📊

🏆 Awards

Dr. Weijun Shen has received more than 10 provincial-ministerial and industry science and technology awards, recognizing his impactful research in petroleum engineering and reservoir simulation. 🏅 His innovative contributions to enhanced oil recovery and numerical reservoir modeling have made significant advances in both academic and industrial sectors. His achievements include awards for excellence in science and innovation from Chinese government bodies and professional societies. 🥇 These accolades celebrate his deep commitment to developing energy-efficient and environmentally sustainable reservoir systems. Additionally, he has earned commendations for international research collaborations, notably during his time at Lawrence Berkeley National Laboratory. 🌎 His recognition as an emerging thought leader in fluid transport and reservoir dynamics underscores the importance of his work in China’s energy transition. Dr. Shen continues to contribute solutions to the global energy landscape, exemplifying leadership and scientific excellence. 🧪

📚 Top Noted Publications 

Dr. Weijun Shen has authored over 70 peer-reviewed papers, 2 monographs, and holds 20 patents, underscoring his prolific scientific output in the field of fluid mechanics and reservoir engineering. His publications appear in prestigious journals such as the Journal of Hydrology, Fuel, Journal of Petroleum Science and Engineering, and Advances in Water Resources. 📝 His most-cited works focus on enhanced oil recovery modeling, multiphase flow in porous media, and reservoir simulation frameworks. Many of his papers have been cited extensively, reflecting his influence in the scientific community. Some highlighted works include:

Conclusion

Dr. Weijun Shen is an exceptionally strong candidate for the Best Researcher Award. His prolific academic output, impactful patents, leadership roles, and national-level recognition make a compelling case. With continued emphasis on international engagement and interdisciplinary collaboration, his already impressive profile could become truly world-leading.

Constantin-Ioan Busuioc | Molecular Pathology | Best Researcher Award

Posted on by sciencefather

Dr. Constantin-Ioan Busuioc | Molecular Pathology | Best Researcher Award

Pathologist, at Saint Mary Clinical Hospital, Romania.

Dr. Constantin-Ioan Busuioc is a distinguished Romanian pathologist with a strong background in both clinical and research domains. Born on January 29, 1985, he has devoted his career to exploring the intricate dynamics of pathology, with special focus on oncologic and hematologic conditions. He is currently affiliated with Saint Mary Clinical Hospital in Bucharest, where he plays a pivotal role in surgical specimen analysis and histopathological diagnostics. Over the years, Dr. Busuioc has amassed considerable experience across institutions in Romania, Switzerland, and Italy, enriching his expertise in diagnostic pathology. His research contributions, particularly in colorectal cancer and immunohistochemistry, have gained recognition in high-impact journals. Known for his clinical precision and academic depth, he bridges the gap between research and real-world pathology. Dr. Busuioc is fluent in English and French, and actively participates in both national and international medical networks. 🧬💉🧪

Professional Profile

Scopus

🎓 Education

Dr. Constantin-Ioan Busuioc’s educational journey exemplifies dedication to academic excellence in medicine. He completed his Medical Doctor (M.D.) degree at the University of Medicine and Pharmacy “Iuliu Haţieganu” in Cluj-Napoca, Romania (2005–2011) 🩺. Subsequently, he pursued a Ph.D. at the same institution from 2015 to 2022, delving into molecular and immunohistochemical aspects of malignancies, particularly colorectal adenocarcinoma. His rigorous research training culminated in several significant publications and conference presentations. In 2021, he obtained a Certificate in Health Services Management from the National School of Public Health, Management and Training, enhancing his administrative and healthcare policy knowledge 📊. Additionally, he undertook a fellowship in Hematopathology at the prestigious European Institute of Oncology in Milan, Italy, under Prof. Dr. Stefano A. Pileri. This diverse academic path has equipped him with a well-rounded perspective, blending clinical pathology, biomedical research, and health systems management. 📚🧠

🏥 Experience

With over a decade of professional experience, Dr. Busuioc has held key pathology roles across several European institutions. His current role at Saint Mary Clinical Hospital (since 2023) involves high-stakes diagnostics, intraoperative evaluations, and necropsies. From 2021 to 2023, he served at the National Institute of Infectious Diseases “Prof. Dr. Matei Balș”, specializing in infectious pathology, autopsies, and immunohistochemistry. 🧫 Earlier roles include long-term service at Oncoteam Diagnostic and previous tenure at Synevo, where he managed complex diagnostic cases involving general and hematopathology. Internationally, he worked as Chef de Clinique at Valais Hospital in Switzerland (2018–2019) and completed an intensive fellowship at the European Institute of Oncology, Italy. His foundational years were spent as a resident at Cluj-Napoca County Hospital, with rotations at specialized hospitals including the Oncology Institute and Gastroenterology Institute. His vast experience shapes his precision in diagnosis and depth in pathology. 🧬🦠

🧠 Research Interests

Dr. Busuioc’s research interests lie at the intersection of molecular oncology, immunohistochemistry, and epithelial-mesenchymal transition (EMT) in gastrointestinal malignancies, particularly colorectal and esophageal cancers. He is also intrigued by gene expression profiling, diagnostic biomarkers, and tumor microenvironment interactions. 🧬 His studies often explore the role of EMT markers like Vimentin and E-cadherin in predicting tumor progression. Utilizing bioinformatics tools, he analyzes molecular pathways and gene signatures such as MMP3 and TESC, aiming to enhance early detection and personalized treatment approaches. He has contributed significantly to the understanding of PD-L1 expression, particularly in esophageal carcinoma, and its immunological implications. Additionally, he has co-authored studies on rare case presentations such as Kikuchi-Fujimoto disease and lymphomas in gynecological tissues. His collaborative approach and interdisciplinary mindset make his research impactful and translational. 🔍🧫

🏆 Awards

Dr. Constantin-Ioan Busuioc has earned recognition for his commitment to excellence in pathology and oncology research. One of the highlights of his academic career is being part of the UEFISCDI-awarded article published in Cancers (Basel), which offered a comprehensive review of MAPK pathways as therapeutic targets in cancer. 🏅 His insightful contributions to colorectal cancer pathology and bioinformatics analysis have garnered attention in Romanian medical circles and abroad. His consistent publication in high-impact journals reflects a commendable academic rigor. He has also been nominated for multiple academic awards through Romanian and European research forums. His interdisciplinary case studies, particularly in complex co-morbidities, showcase his versatility as both a clinician and a researcher. These recognitions not only validate his scientific acumen but also reinforce his status as a dedicated and innovative medical professional. 🌟📖

📚Top Noted Publications

Dr. Busuioc has co-authored 12+ peer-reviewed articles in reputable international journals, reflecting his impactful work in pathology and molecular oncology:

  1. Aberrant Immunohistochemical Expression in Colorectal Adenocarcinoma
    Chirurgia (Bucur), 2022

    • Focus: Aberrant IHC patterns in colorectal cancer

    • Citations: 5

    • Notes: Highlights novel expression markers potentially linked to prognosis and therapy responsiveness.

  2. MMP3 & TESC in Colon Adenocarcinoma
    BioMedInformatics, 2022

    • Focus: Role of MMP3 and TESC genes in colon cancer progression using computational biology tools

    • Citations: 2

  3. EMT Gene Signature & Prognosis in Colon Adenocarcinoma
    Journal of Personalized Medicine, 2021

    • Focus: EMT-related gene expression linked to prognosis and patient stratification

    • Citations: 10

    • Impact: Widely referenced in personalized therapy literature.

  4. PD-L1 Expression in Esophageal Carcinomas
    Chirurgia (Bucur), 2022

    • Focus: PD-L1 immunostaining in esophageal cancer subtypes

    • Notes: Adds data to the ongoing debate on immunotherapy eligibility.

  5. MAPK Pathways Review: Biological Mechanisms & Therapeutic Targets in Oncology
    Cancers (Basel), 2019

    • Focus: Comprehensive review of MAPK signaling in cancer

    • Citations: 100+

    • Recognition: Award-winning article, highly cited in targeted therapy discussions.

  6. Multidisciplinary Team in Rectal Cancer Management: Integration & Outcomes
    Clujul Med, 2017

    • Focus: Clinical coordination in colorectal cancer treatment

    • Notes: Addresses practical framework for collaborative cancer care.

🩺 Internal Medicine, Autoimmunity & Rare Conditions

  1. Case of Acute Polyarthritis with Severe Comorbidity
    Internal Medicine, 2021

    • Focus: Complex internal medicine case with overlapping rheumatological and systemic features

  2. Sarcoidosis Associated with Solid Pseudopapillary Tumor: A Diagnostic Rarity
    Romanian Journal of Internal Medicine, 2022

    • Focus: Uncommon tumor presentation in a patient with sarcoidosis

  3. Episcleritis in Granulomatosis with Polyangiitis: A Diagnostic Challenge
    Romanian Journal of Ophthalmology, 2021

    • Focus: Ocular manifestation of a systemic vasculitis

  4. Kikuchi-Fujimoto Disease Mimicking Systemic Lupus Erythematosus
    Romanian Journal of Rhinology, 2022

    • Focus: Autoimmune overlap and diagnostic pitfalls

  5. Primary Gynecological Lymphomas: A Behavioural Case Perspective
    Annals of Behavioural Science, 2018

    • Focus: Behavioral and clinical aspects of gynecological lymphoma diagnosis and management

Conclusion

Dr. Constantin-Ioan Busuioc is a strong candidate for a Best Researcher Award, especially in the field of oncopathology, molecular diagnostics, and histopathology. His blend of clinical practice, interdisciplinary research, and international experience makes him highly competitive. With enhanced visibility in research leadership roles and international scholarly forums, his profile would be further elevated to a global best researcher standard.

King-cheong LAM | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Dr. King-cheong LAM | Molecular Biology | Best Researcher Award

Senior Lecturer, at The School of Professional Education and Executive Development (SPEED), The Hong Kong Polytechnic University, Hong Kong.

Dr. LAM King-cheong Antony is a seasoned academic currently serving as a Senior Lecturer in the Division of Science, Engineering and Health Studies at the College of Professional and Continuing Education (CPCE), The Hong Kong Polytechnic University. With a rich interdisciplinary background in physics and engineering education, Dr. Lam has consistently contributed to innovative teaching methods and research initiatives. His career journey from a secondary school teacher to a respected university lecturer is marked by dedication to student development, academic leadership, and community outreach. 📘 His roles as Programme Leader and Co-Investigator in prestigious funded projects reflect his commitment to applied research and educational advancement. Through his work in nanotechnology, sustainable energy, and smart sensor systems, Dr. Lam exemplifies a professional devoted to shaping the future of science education and technology for sustainable urban living. 🌱

Professional Profile

Scopus

ORCID

🎓 Education

Dr. Antony Lam’s academic path is built on a solid foundation in science and education. 🎓 He earned his Doctor of Philosophy from The Hong Kong Polytechnic University in 2017, where he focused on gas sensing materials using graphene-based composites. Prior to that, he completed his Master of Philosophy (2008) and Bachelor of Science in Physics (2005) at The University of Hong Kong, establishing his grounding in physical sciences. Recognizing the importance of pedagogy in science, he also pursued a Postgraduate Diploma in Education from The University of Hong Kong in 2010, equipping himself with the skills to bridge research and teaching. This rare blend of scientific rigor and educational expertise empowers him to mentor students and lead cross-disciplinary research with confidence. 🧠 His training has laid the foundation for a career devoted to both scientific discovery and academic development.

💼 Experience

Dr. Lam’s professional career spans across secondary and tertiary education sectors. 🏫 From 2007 to 2012, he began his journey as a science teacher at Heung To Secondary School (TKO), where he nurtured young minds with enthusiasm for physics. In 2018, he transitioned to higher education as a Lecturer at CPCE, The Hong Kong Polytechnic University, and was promoted to Senior Lecturer in 2024. Over the years, Dr. Lam has taken on several key academic leadership roles, including Programme Leader for Associate in Engineering and Higher Diploma in Aircraft Services Engineering, and Assistant Programme Leader for the BEng (Hons) in Mechanical Engineering. 💼 These positions not only reflect his pedagogical expertise but also his capability in curriculum innovation and academic governance. Dr. Lam’s dedication to bridging practical engineering with academic training is central to his career mission of advancing applied science education. ⚙️

🔬 Research Interests

Dr. Lam’s research interests lie at the intersection of nanotechnology, green energy, sustainable materials, and smart sensing systems. 🌍 His work explores the fabrication of advanced materials such as tin-based perovskites, graphene composites, and aluminum-ion batteries to enhance energy efficiency and sensor capabilities. A significant part of his research addresses real-world sustainability challenges—ranging from developing natural fiber/concrete composites for eco-friendly buildings to ionic-liquid-based gas sensors for smart cities. 🏙️ He is also actively investigating thermal and mechanical properties of biomaterials, including mycelium-based composites for biomedical applications. His interdisciplinary approach combines physics, chemistry, and engineering to produce applicable technologies for energy and healthcare sectors. Through multiple funded projects and international conferences, Dr. Lam has established himself as a researcher committed to translational science for societal impact. 🌱

🏅 Awards

Dr. Lam’s research excellence has earned him both institutional recognition and competitive external grants. 🏆 In 2023, he received the KML Third Prize (HK$200,000) from the Koo Meng Li and Koo Mi Wen Na Charitable Foundation Limited for his project on natural fiber/concrete composites for sustainable buildings. He has been a Principal Investigator and Co-Investigator in numerous high-impact projects, including a nearly HK$1 million RGC-funded project on mycelium-based insoles for diabetic care. 💰 These awards and grants highlight his innovative work in sustainable technology and material science. Dr. Lam’s recognition not only reflects his technical acumen but also his leadership in building collaborative, real-world solutions. His consistent involvement in cutting-edge research underscores his role as a forward-thinking academic in science and engineering education. 🧪

📚 Top Noted Publications

Dr. Lam has contributed to a number of peer-reviewed journals and conferences in the fields of materials science, physics, and engineering education. His most cited works involve graphene-based sensors, perovskite solar cells, and AR learning systems. 📖 His publication list includes:

1. Ahmed, S. B., Kan, H. W., Lam, K. C., & Yip, C. T. (2025)

Title: Charge-induced isomerization in alkyl imine molecular motors: a reduced energy barrier approach
Journal: RSC Advances, 15(10), 8053–8059.

  • Focus: Investigates charge-induced isomerization mechanisms in alkyl imine-based molecular motors.

  • Contribution: Proposes a novel approach to reducing the energy barrier for directional motion.

  • Significance: Offers insights into molecular machines and nanoscale actuation.

2. Wang, Y. D., et al., incl. Lam, K. C. (2024)

Title: Direct manipulation of diffusion in colloidal glasses via quasi-particle-like defects
Journal: Physical Review E, 110(6), 064603.

  • Focus: Explores defect-driven dynamics in colloidal glasses.

  • Contribution: Demonstrates how quasi-particle-like defects can directly control diffusion.

  • Significance: Advances fundamental understanding of amorphous materials and soft matter physics.

3. Li, K. C., Lam, K. C., et al. (2024)

Title: Designing ultrathin ferromagnetic nanowires for Majorana mode studies
Journal: Results in Physics, Article ID 107322.

  • Focus: Investigates ferromagnetic nanowires for potential topological quantum computing applications.

  • Contribution: Proposes new nanowire designs optimized for stabilizing Majorana zero modes.

  • Significance: Supports progress in solid-state quantum computation.

4. Lo, K., Ng, J., Chau, & Lam, A. (2023)

Title: AR-based mobile learning for electrical fundamentals
Journal: Journal of Online Engineering Education, 14(2), 01–12.

  • Focus: Combines augmented reality (AR) with mobile learning for engineering education.

  • Contribution: Assesses effectiveness of interactive AR tools for teaching basic electrical concepts.

  • Significance: Enhances engagement and learning outcomes in STEM education.

5. Lam, K. C., Huang, B., & Shi, S. Q. (2017)

Title: Room-temperature methane gas sensing with graphene-SnO₂
Journal: Journal of Materials Chemistry A, 5, 11131–11142.

  • Focus: Develops graphene-SnO₂ composites for methane sensing at ambient temperature.

  • Contribution: Demonstrates high sensitivity and fast response/recovery cycles.

  • Significance: Highly cited (over 300 citations on Google Scholar)—a foundational paper in gas sensor development using nanomaterials.

Conclusion

Dr. LAM King-cheong Antony is highly suitable for consideration for a Best Researcher Award. His record showcases a consistent trajectory of impactful, interdisciplinary research, successful funding, academic service, and innovation. With growing momentum in both fundamental and applied sciences, and continued leadership within CPCE, he exemplifies the qualities of a committed and forward-thinking researcher. Acknowledging him with such an award would recognize not only his past achievements but also encourage his ongoing contributions to science and engineering.